Spending and Utilization on Drugs Prescribed by Otolaryngologists to Medicare Beneficiaries, 2013 to 2017

CONCLUSIONS: Spending on drugs prescribed by otolaryngologists to Medicare Part D beneficiaries declined between 2013 and 2017 in part due to a transition from brand name drugs to lower-cost generic equivalents.PMID:34628959 | DOI:10.1177/00034894211050434

Source: The Annals of Otology, Rhinology, and Laryngology - October 11, 2021 Category: ENT & OMF Authors: Shivani A Shah Lauren E Miller Roy Xiao Alan Workman Lucy Xu Vinay K Rathi Source Type: research